ARTICLE | Company News
Biofrontera Pharmaceuticals AG, bioLeads deal
October 15, 2001 7:00 AM UTC
The companies will collaborate to discover compounds for CNS diseases, initially in the areas of depression and pain, for outlicensing or joint development and marketing.. Biofrontera will identify an...